Tokyo Tape
Sign in
← Stella Pharma

Annual report

4888.TEDINET S100TW8I
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 77
MetricValuePeriodScopeSource row
Revenue¥269m2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥229m2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥100m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥206m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥760m2023-04-01 → 2024-03-31StandaloneOperating income
Operating income−¥807m2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income−¥760m2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥776m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥764m2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥656m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥959m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥761m2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax−¥776m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income−¥764m2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥779m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income−¥768m2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥659m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income−¥962m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥3.8bnat 2024-03-31StandaloneAssets
Total assets¥4.3bnat 2023-03-31StandaloneAssets
Total assets¥4.7bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.7bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.4bnat 2024-03-31StandaloneLiabilities
Total liabilities¥1.6bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥2.4bnat 2024-03-31StandaloneNet assets
Net assets / equity¥2.8bnat 2023-03-31StandaloneNet assets
Net assets / equity¥3.1bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥231mat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥690mat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.1bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥2.7bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥2.0bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥838mat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.0bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥877m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥828m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥773m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥914m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥9m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥30m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥351m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥23m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥228m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥292m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.8bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥332m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥69m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-24.662023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.972022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.342021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.92020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-61.682019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥75.9at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥91.51at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥107.39at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥11.46at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥34.57at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio62.0%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio63.3%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.3%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio11.3%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio25.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued31,225,500at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued29,966,300at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,676,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued20,137,400at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,960,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees44at 2024-03-31StandaloneNumber of employees
Employees46at 2023-03-31StandaloneNumber of employees
Employees43at 2022-03-31dStandaloneNumber of employees
Employees43at 2021-03-31dStandaloneNumber of employees
Employees42at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 825
ItemContextValueUnit
Provision for bonuses gaCurrentYearDuration_NonConsolidatedMember365000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember6613000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember5397000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember14587000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember13613000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember374345000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember393555000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration_NonConsolidatedMember374345000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration_NonConsolidatedMember393555000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2024-06-28
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第17期（自　2023年４月１日　至　2024年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Company name in english cover pageFilingDateInstantSTELLA PHARMA CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　上原　幸樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)(06)4707-1516（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員総務部長　小川　礼隆
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)(06)4707-1516（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員総務部長　小川　礼隆
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE35496
Fund codeFilingDateInstant－
Security codeFilingDateInstant48880
Filer name in japaneseFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Filer name in englishFilingDateInstantSTELLA PHARMA CORPORATION
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2024-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2024-03-31
Previous fiscal year start dateFilingDateInstant2022-04-01
Comparative period end dateFilingDateInstant2023-03-31
Previous fiscal year end dateFilingDateInstant2023-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass